Learn if You Have a Claim Against Sanofi-Aventis

Antibiotic May Cause Serious Liver Damage

The label of widely prescribed antibiotic Ketek will be updated to reflect reports of severe liver problems, including several deaths, associated with its use, the drug's maker and health officials confirmed. Sanofi-Aventis' Ketek will carry a bold-type warning about reports of liver failure and severe injury, some of them fatal, in patients treated with the drug.

Please explain any problems you have had in relation to this case:

Personal Information

First Name

Last Name

Street / Apt /

City, State Zip

Home Phone & Evening Phone (Same) . . & . .

E-Mail Address

Confirm E-Mail

Date Issue/Problem

Terms & Conditions
I acknowledge that I have read and understand and agree to the following legal policies.

Certain features of Lawcash.com require a login - please simply choose a password to continue.

Password

Confirm Password

I'd like to become a Lawcash.com member, receive a free class action ebook, and free class action and recall alerts. Billions of dollars are available each year and I'd like to claim my fair share from bad corporations.

Submit

Other Drugs / Medical Cases of Interest

Central States Health and Life Company of Omaha "Cancer and Dreaded Disease" Policyholders Agree to $20 Million Settlement

What good is insurance if it doesn’t pay up when you need it? The parties have reached a $20 million settlement in an action filed against Midwestern insurance company Central States Health and Life Company of Omaha on behalf of cancer patients and their families who alleged that the company refused to pay for certain treatments allegedly covered under cancer insurance policies it sold, in violation of its contracts with the patients. Persons eligible to take part in the settlement should contact class counsel for more information.

Allos Therapeutics Accused of Finding an Experimental Group to Make RSR13 Anticancer Drug Look Good

Several class actions have been filed against biopharmaceutical research company Allos Therapeutics, Inc., (Nasdaq:ALTH) and certain of its officers and directors by stockholders who purchased the company's common stock between April 23, 2003, and April 29, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.

Kentucky Residents Deemed Ineligible for Medicare Win Chance for Reevaluation

The parties have reached a tentative settlement apparently valued at more than $13 million in a class-action filed against the Kentucky Department for Medicaid Services and the Kentucky State Cabinet for Health Services on behalf of thousands of Kentucky residents who lost their eligibility for nursing home or in-home care because of stricter rules that were enacted in April 2003. Persons eligible to take part in the reinstatement of care should contact the attorneys for the class for more information.

Women Sue Maker of Birth Control Patch

Ten women filed a lawsuit against Johnson & Johnson and its subsidiary Ortho McNeil on July 25, 2005, claiming the birth control device the company manufactures caused them to suffer strokes and blood clots.

Class Action Filed Against New York Office of State Parks

Lawyers in Seattle, Washington filed a lawsuit against the New York Office of State Parks on behalf of over 3,200 people who became ill with Cryptosporidiosis after visiting the Sprayground at Seneca Lake State Park in July and August, 2005. The notice was filed on behalf of Tricia Van Putte and her two young children, who are the named plaintiffs in the class action lawsuit, and who became ill with Cryptosporidium infections after visiting the Sprayground.

California Pharmacists File Suit against Medco and Merck for Alleged Anticompetitive Behavior

A company is caught engaging in anticompetitive behavior, either state or federal antitrust law may be used against it. A class action has been filed against Medco Health Solutions, Inc. and Merck & Company on behalf of California pharmacists, who allege that the companies engaged in anticompetitive behavior in violation of state antitrust law.